SMAD2 and non-small cell lung carcinoma: Our data strongly suggest that XIST modulates TGF-β signaling by directly interacting with SMAD2, which impacts on apoptosis, DDP-mediated pyroptosis, and resistance to DDP in NSCLC cells.